血液製品市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、類型、應用、地區和競爭格局分類，2021-2031年

全球血液製品市場預計將從 2025 年的 441.4 億美元大幅成長至 2031 年的 643.7 億美元，複合年成長率為 6.49%。

該市場涉及對全血進行系統性採集和篩檢，用於各種醫療用途，並分離出紅血球、血小板和血漿等重要的治療成分。推動這一市場成長的關鍵因素包括慢性血液疾病盛行率的上升，以及複雜外科手術和創傷病例中輸血需求的不斷成長。

此外，人口老化是獨特的成長要素。老年族群通常需要長期輸血治療以控制疾病，這不斷推高了血液製品技術及相關耗材的需求。然而，市場面臨著許多挑戰，包括供應鏈穩定性不足和長期庫存短缺，這些都阻礙了必需品的及時供應。捐血留存率的波動以及維持充足庫存的物流難題進一步加劇了這個問題。例如，根據血液與生物療法促進協會（Association for the Advancement of Blood & Biotherapies）的數據，到2025年12月，供應限制常常導致O型陰性血和B型陰性血的等待時間長達48小時或更久。這種延誤凸顯了營運方面的脆弱性，可能會阻礙市場的進一步擴張。

市場促進因素

血液製品產業的成長主要得益於新型口服抗凝血劑（NOAC）的日益普及，尤其是源自血漿的先進治療方法。隨著醫療專業人員擴大選擇針對免疫力缺乏和自體免疫神經病變等疾病的標靶治療，對精確的分餾和成分分離技術的需求也日益成長，以確保產品的純度和療效。這種需求的激增體現在行業領導者的強勁業績上，這些企業正在擴大業務以滿足全球治療需求。例如，在強勁的全球需求支撐下，Griffols公司於2025年2月公佈其免疫球蛋白業務全年成長15.3%。

同時，急診創傷病例的增加和院前急救流程的演進正在加速市場發展。醫療系統擴大採用將全血和特定成分治療方法直接裝載到救護車上的方式，以提高嚴重出血創傷患者的生存率。這種策略轉變需要擴大社區血液處理能力，並在傳統醫院環境之外提供專業的血液儲存解決方案。根據美國血液中心協會（America's Blood Centers）統計，2022年至2024年間，為院前急診計畫提供血液製品的社區血液中心數量幾乎加倍，達到34家。這種擴張有助於緩解慢性病管理帶來的持續壓力。美國癌症協會預測，2025年美國將新增2,041,910例癌症病例，除了緊急醫療用途外，輸血需求也將持續居高不下。

市場挑戰

血液製品市場營運環境高度動盪，供應鏈不穩定，庫存長期短缺。當採血中心無法維​​持充足的庫存水準時，加工所需原料的短缺必然導致血液生產技術和耗材使用量的下降。這種營運瓶頸嚴重限制了市場參與企業擴大加工能力和高效滿足醫院訂單的能力。此外，捐血數量的不確定性導致營運效率低下，迫使各機構在未滿載運作的情況下，仍需承擔設備維護及人事費用等固定成本。

這些反覆出現的短缺直接減少了可用於治療的血液製品數量，導致加工企業的累計停滯不前。無法確保全血的穩定供應意味著醫療機構的需求往往無法被滿足，從而擾亂整個市場生態系統。例如，美國紅十字會報告稱，2024年8月全國血液供應量下降了25%以上，導致庫存嚴重短缺。如此嚴重的短缺阻礙了必要的篩檢和分離流程的持續實施，最終限制了血液短缺時期整體市場的成長潛力。

市場趨勢

病原體減少和去活化技術的整合正在從根本上改變市場動態，其首要任務是確保輸血安全並延長血液庫存的保存期限。血液中心正在迅速採用先進的系統，利用光化學過程來去活化血小板和血漿中的病原體，從而有效降低細菌污染和輸血相關感染疾病的風險，而無需僅依賴檢測方法。這項技術變革不僅提高了病人安全，也顯著延長了血液成分的保存期限，直接解決了供應鏈中嚴重的廢棄物問題。例如，Cerus公司報告稱，截至2025年11月，其產品銷售額年增15%，這一成長主要歸功於全球對其病原體減少的血小板和纖維蛋白原系統的強勁需求。

另一個重要趨勢是自動化血液成分分離系統的應用。這些系統最佳化了處理流程，以滿足日益成長的高產量治療產品需求。各機構正從人工分離方法過渡到先進的封閉回路型自動化平台，這些平台能夠高效地分離全血並透過血球分離術提取特定成分，從而提高營運能力和產品一致性。這種轉變有助於擴大生產擴充性，同時減少對人工作業和處理錯誤的依賴，使各機構能夠最大限度地有效利用每次捐血。例如，Hemonetics公司在2025年11月發布的2026年第二季財報中，其血漿業務部門在一次性供應合約的基礎上實現了19%的有機銷售成長。這反映了業界對新一代自動化血液採集和分離設備的快速採用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球血液製品市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品（全血、血液成分、血液製品）
  • 按類型（血小板凝集抑制劑、纖溶劑、抗凝血劑）
  • 依應用（血小板增多症、肺動脈栓塞、腎功能障礙、與心絞痛相關的血管併發症等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美血液製品市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲血液製品市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區血液製品市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲血液製品市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美血液製品市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球血液製品市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Pfizer, Inc.
• Bristol-Myers Squibb Company
• Leo Pharma A/S
• Sanofi SA
• Xiamen Hisunny Chemical Co., LTD
• AstraZeneca plc
• Baxter International Inc
• Portola Pharmaceuticals, Inc.
• GlaxoSmithKline PLC
• Shandong East Chemical Industry Co.

第16章 策略建議

第17章：關於研究公司及免責聲明

The global blood preparation market is projected to expand significantly, rising from USD 44.14 billion in 2025 to USD 64.37 billion by 2031, demonstrating a compound annual growth rate of 6.49%. This market involves the methodical collection, screening, and fractionation of whole blood into vital therapeutic components like red blood cells, platelets, and plasma for various medical uses. Key factors driving this growth include the increasing incidence of chronic hematological disorders and a heightened need for blood transfusions during intricate surgical procedures and trauma incidents.

Moreover, the growing elderly population presents a unique growth driver, as this demographic frequently requires prolonged blood-based treatments for disease management, which consistently fuels the demand for blood preparation technologies and associated consumables. However, the market faces a substantial hurdle concerning the stability of its supply chain and persistent inventory shortages, which hinder the timely availability of essential products. This issue is compounded by fluctuating donor retention rates and logistical difficulties in maintaining adequate stockpiles; for instance, according to the Association for the Advancement of Blood & Biotherapies, obtaining O-negative and B-negative blood in December 2025 often took forty-eight hours or more due to supply limitations. Such delays underscore an operational vulnerability that could impede broader market expansion.

Market Driver

The blood preparation sector is significantly propelled by the increasing adoption of novel oral anticoagulants (NOACs) and advanced therapeutic options, particularly those derived from plasma. As healthcare providers increasingly opt for targeted treatments for conditions like immune deficiencies and autoimmune neuropathies, there is a heightened requirement for precise fractionation and component separation technologies to guarantee product purity and effectiveness. This surge in demand is evident in the strong financial performance of leading industry players who are scaling operations to meet global therapeutic needs; for example, Grifols reported a robust 15.3% full-year growth in its immunoglobulin franchise in February 2025, driven by strong global underlying demand.

Concurrently, the rising volume of emergency trauma cases and the evolution of prehospital care protocols are accelerating market momentum. Healthcare systems are increasingly integrating whole blood and specific component therapies directly into emergency response vehicles to improve survival rates for trauma victims experiencing severe hemorrhage. This strategic shift necessitates the expansion of localized processing capabilities and specialized storage solutions beyond traditional hospital environments. According to America's Blood Centers, the number of community blood centers providing blood products for specialized prehospital programs nearly doubled to 34 between 2022 and 2024. This operational expansion helps balance the ongoing pressures of chronic disease management, as projected new cancer cases in the United States, estimated at 2,041,910 in 2025 by the American Cancer Society, maintain a consistently high baseline demand for transfusions alongside emergency utilization.

Market Challenge

The blood preparation market operates in a volatile environment characterized by supply chain instability and persistent inventory shortages. When blood collection centers cannot maintain adequate stock levels, the utilization of preparation technologies and consumables inevitably declines due to insufficient raw material for processing. This operational bottleneck significantly restricts the ability of market participants to scale their processing capabilities and efficiently fulfill hospital orders. Furthermore, the unpredictable nature of donor turnout leads to operational inefficiencies, forcing facilities to operate below their full capacity while still incurring fixed costs for equipment maintenance and labor.

These recurring shortages directly reduce the volume of blood products available for therapeutic applications, thereby stalling revenue recognition for processing entities. The inability to secure a consistent inflow of whole blood means that demand from healthcare providers often remains unmet, causing disruptions throughout the market ecosystem. For instance, the American Red Cross reported a national blood supply drop of over 25 percent in a single month during August 2024, creating a critical inventory gap. Such significant deficits impede the consistent application of essential screening and fractionation processes, ultimately limiting the overall market growth potential during periods of scarcity.

Market Trends

The integration of Pathogen Reduction and Inactivation Technologies is fundamentally reshaping market dynamics by prioritizing transfusion safety and extending the longevity of blood inventories. Blood centers are rapidly deploying advanced systems that employ photochemical processes to neutralize pathogens in platelets and plasma, thereby effectively minimizing the risk of bacterial contamination and transfusion-transmitted infections without solely relying on detection methods. This technological shift not only enhances patient safety profiles but also significantly extends the viable shelf life of components, directly addressing critical wastage challenges within the supply chain. For example, Cerus Corporation reported a 15% year-over-year increase in product revenue in November 2025, a surge largely attributed to the robust global demand for its pathogen-reduced platelet and fibrinogen systems.

Another significant trend is the Adoption of Automated Blood Component Separation Systems, which are optimizing processing workflows to meet the escalating requirement for high-yield therapeutic products. Facilities are increasingly transitioning from manual separation methods to sophisticated closed-loop automated platforms that efficiently fractionate whole blood or collect specific components via apheresis, consequently improving operational throughput and product consistency. This transition supports scalable production while simultaneously reducing labor dependencies and processing errors, enabling centers to maximize the utility of every donation. Haemonetics Corporation's Plasma segment, for instance, achieved an organic revenue growth of 19% (excluding transitional supply agreements) in its Q2 Fiscal 2026 results in November 2025, reflecting the accelerated industry uptake of next-generation automated collection and separation devices.

Key Market Players

• Pfizer, Inc.
• Bristol-Myers Squibb Company
• Leo Pharma A/S
• Sanofi S.A.
• Xiamen Hisunny Chemical Co., LTD
• AstraZeneca plc
• Baxter International Inc
• Portola Pharmaceuticals, Inc.
• GlaxoSmithKline PLC
• Shandong East Chemical Industry Co.

Report Scope

In this report, the Global Blood Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Preparation Market, By Product

• Whole Blood
• Blood Components
• Blood Derivatives

Blood Preparation Market, By Type

• Platelet Aggregation Inhibitors
• Fibrinolytics
• Anticoagulants

Blood Preparation Market, By Application

• Thrombocytosis
• Pulmonary Embolism
• Renal Impairment
• Angina Blood Vessel Complications
• Others

Blood Preparation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Preparation Market.

Available Customizations:

Global Blood Preparation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Preparation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Whole Blood, Blood Components, Blood Derivatives)
  • 5.2.2. By Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants)
  • 5.2.3. By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Blood Preparation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Preparation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Blood Preparation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Blood Preparation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application

7. Europe Blood Preparation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Preparation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
  • 7.3.2. France Blood Preparation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Blood Preparation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Blood Preparation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Blood Preparation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application

8. Asia Pacific Blood Preparation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Preparation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
  • 8.3.2. India Blood Preparation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Blood Preparation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Blood Preparation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Blood Preparation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application

9. Middle East & Africa Blood Preparation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Preparation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Blood Preparation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Blood Preparation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application

10. South America Blood Preparation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Preparation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Blood Preparation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Blood Preparation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Preparation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Pfizer, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bristol-Myers Squibb Company
• 15.3. Leo Pharma A/S
• 15.4. Sanofi S.A.
• 15.5. Xiamen Hisunny Chemical Co., LTD
• 15.6. AstraZeneca plc
• 15.7. Baxter International Inc
• 15.8. Portola Pharmaceuticals, Inc.
• 15.9. GlaxoSmithKline PLC
• 15.10. Shandong East Chemical Industry Co.

16. Strategic Recommendations

17. About Us & Disclaimer